Applied and Computational Mathematics and Statistics
Search criteria:
List of files deposited in CurateND that match your search criteria
-
- Inventor(s):
- Steven Buechler, Amanda B. Hummon
- Patent Number:
- US 9580756 B2
- Description:
Compositions/methods for employing fresh-frozen or FFPE colon cancer tissue in left side colon cancer (LCC) and right-side colon cancer (RCC) disease patients for risk of relapse assessment/stratification is provided (3 strata and a 4 strata methodology). An RCC gene panel of 4 genes (FAM69A, CDX2, FAM84A, ITGA3), and 9 genes (FAM69A, CDX2, ITGA3, FAM84A, ITPRIP, RAB3B, SMAD3, PCSK5, MMP28), is provided. An LCC gene panel of 4 genes (NOX4, WNT5A, MMP3, IBSP), and a 9 genes (MMP3, WINT5A, NOX4…
- Date Issued:
- 2017-02-28
-
- Inventor(s):
- Steven Buechler, Amanda B. Hummon
- Patent Number:
- US 9464328 B2
- Description:
Genetic biomarkers for left side colon cancer (LCC) (such as expression levels of an RNA transcript or expression product of NOX4, MMP3, or a combination) and right side colon cancer (RCC) (such as expression levels of an RNA transcript or expression product of CDCX2, FAM69A, or a combination), are disclosed. Methods for using the biomarkers in providing a prognosis of relapse-free survival probability in patients having LCC or RCC are also presented. Prognostic panels using gene expression v…
- Date Issued:
- 2016-10-11
-
- Inventor(s):
- Steven Buechler, Amanda B. Hummon
- Patent Number:
- US 10,087,489 B2
- Description:
Genetic biomarkers for left side colon cancer (LCC) (such as expression levels of an RNA transcript or expression product of NOX4, MMP3, or a combination) and right side colon cancer (RCC) (such as expression levels of an RNA transcript or expression product of CDCX2, FAM69A, or a combination), are disclosed. Methods for using the biomarkers in providing a prognosis of relapse-free survival probability in patients having LCC or RCC are also presented. Prognostic panels using gene expression v…
- Date Issued:
- 2018-10-02